Characterisation of the interaction of neuropilin-1 with heparin and a heparan sulfate mimetic library of heparin-derived sugars

PeerJ

Volumn 2014, Issue 1, 2014, Pages

  Uniewicz, Katarzyna A ^a   Ori, Alessandro ^b   Ahmed, Yassir A ^c   Yates, Edwin A ^c   Fernig, David G ^c  

^a QIAGEN GMBH   (Germany)

^b EUROPEAN MOLECULAR BIOLOGY LABORATORY   (Germany)

^c UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Glycosaminoglycan; Heparan sulfate; Heparin; Neuropilin; Protein polysaccharide interactions

Indexed keywords

HEPARAN SULFATE; HEPARIN; HEPARIN BINDING PROTEIN; NEUROPILIN 1;

AFFINITY CHROMATOGRAPHY; ANGIOGENESIS; ANIMAL TISSUE; ARTICLE; BINDING ASSAY; BIOSENSOR; CONTROLLED STUDY; DATA ANALYSIS; DIFFERENTIAL SCANNING FLUORIMETRY; DUAL POLARISATION INTERFEROMETRY; GENE MAPPING; GLYCOSYLATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IMMUNE RESPONSE; INTERFEROMETRY; MASS SPECTROMETRY; MEASUREMENT; NONHUMAN; OLIGOMERIZATION; PEPTIDE ANALYSIS; PROTEIN INTERACTION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY; TIME OF FLIGHT MASS SPECTROMETRY; VASCULARIZATION;

EID: 84903852019     PISSN: None     EISSN: 21678359     Source Type: Journal    
DOI: 10.7717/peerj.461     Document Type: Article

References (54)

1. Appleton BA, Wu P, Maloney J, Yin J, LiangWC, Stawicki S, Mortara K, Bowman KK, Elliott JM, Desmarais W, Bazan JF, Bagri A, Tessier-Lavigne M, Koch AW, Wu Y, Watts RJ, Wiesmann C. 2007. Structural studies of neuropilin/antibody complexes provide insights into semaphorin and VEGF binding. EMBO Journal 26:4902-4912 DOI 10.1038/sj.emboj.7601906.
2. Bruder D, Probst-Kepper M, Westendorf AM, Geffers R, Beissert S, Loser K, von Boehmer H, Buer J, Hansen W. 2004. Neuropilin-1: a surface marker of regulatory T cells. European Journal of Immunology 34:623-630 DOI 10.1002/eji.200324799.
3. Duchesne L, Octeau V, Bearon RN, Beckett A, Prior IA, Lounis B, Fernig DG. 2012. Transport of fibroblast growth factor 2 in the pericellular matrix is controlled by the spatial distribution of its binding sites in heparan sulfate. PLoS Biology 10:e1001361 DOI 10.1371/journal.pbio.1001361.
4. Edwards PR, Gill A, Pollard-Knight DV, Hoare M, Buckle PE, Lowe PA, Leatherbarrow RJ. 1995. Kinetics of protein-protein interactions at the surface of an optical biosensor. Analytical Biochemistry 231:210-217 DOI 10.1006/abio.1995.1522.
5. Eswar N, Eramian D, Webb B, Shen MY, Sali A. 2008. Protein structure modeling with MODELLER. Methods in Molecular Biology 426:145-159 DOI 10.1007/978-1-60327-058-8 8.
6. Fazili KM, Mir MM, Qasim MA. 1993. Changes in protein stability upon chemical modification of lysine residues of bovine serum albumin by different reagents. Biochemistry and Molecular Biology International 31:807-816.
7. Fernig DG. 2001. Optical biosensor techniques to analyze protein-polysaccharide interactions. Methods in Molecular Biology 171:505-518 DOI 10.1385/1-59259-209-0:505.
8. Fuh G, Garcia KC, de Vos AM. 2000. The interaction of neuropilin-1 with vascular endothelial growth factor and its receptor flt-1. Journal of Biological Chemistry 275:26690-26695.
9. Fukasawa M, Matsushita A, Korc M. 2007. Neuropilin-1 interacts with integrin beta1 and modulates pancreatic cancer cell growth, survival and invasion. Cancer Biology & Therapy 6:1173-1180 DOI 10.4161/cbt.6.8.4363.
10. Geretti E, Shimizu A, Kurschat P, Klagsbrun M. 2007. Site-directed mutagenesis in the b-neuropilin-2 domain selectively enhances its affinity to VEGF165, but not to semaphorin 3F. Journal of Biological Chemistry 282:25698-25707 DOI 10.1074/jbc. M702942200.
11. Giger RJ, Urquhart ER, Gillespie SK, Levengood DV, Ginty DD, Kolodkin AL. 1998. Neuropilin-2 is a receptor for semaphorin IV: insight into the structural basis of receptor function and specificity. Neuron 21:1079-1092 DOI 10.1016/S0896-6273(00)80625-X.
12. Gitay-Goren H, Soker S, Vlodavsky I, Neufeld G. 1992. The binding of vascular endothelial growth factor to its receptors is dependent on cell surface-associated heparin-like molecules. Journal of Biological Chemistry 267:6093-6098.
13. Holm L, Park J. 2000. DaliLite workbench for protein structure comparison. Bioinformatics 16:566-567 DOI 10.1093/bioinformatics/16.6.566.
14. Karpanen T, Heckman CA, Keskitalo S, Jeltsch M, Ollila H, Neufeld G, Tamagnone L, Alitalo K. 2006. Functional interaction of VEGF-C and VEGF-D with neuropilin receptors. Faseb Journal 20:1462-1472 DOI 10.1096/fj.05-5646com.
15. Koyama H, Yamamoto H, Nishizawa Y. 2007. RAGE and soluble RAGE: potential therapeutic targets for cardiovascular diseases. Missouri Medicine 13:625-635 DOI 10.2119/2007-00087.Koyama.
16. Lindahl U, Kusche-Gullberg M, Kjellen L. 1998. Regulated diversity of heparan sulfate. Journal of Biological Chemistry 273:24979-24982 DOI 10.1074/jbc.273.39.24979.
17. Lu Y, Xiang H, Liu P, Tong RR, Watts RJ, Koch AW, Sandoval WN, Damico LA, Wong WL, Meng YG. 2009. Identification of circulating neuropilin-1 and dose-dependent elevation following anti-neuropilin-1 antibody administration. mAbs 1:364-369 DOI 10.4161/mabs.1.4.8885.
18. Lyon M, Deakin JA, Rahmoune H, Fernig DG, Nakamura T, Gallagher JT. 1998. Hepatocyte growth factor scatter factor binds with high affinity to dermatan sulfate. Journal of Biological Chemistry 273:271-278 DOI 10.1074/jbc.273.1.271.
19. Makinen T, Olofsson B, Karpanen T, Hellman U, Soker S, Klagsbrun M, Eriksson U, Alitalo K. 1999. Differential binding of vascular endothelial growth factor B splice and proteolytic isoforms to neuropilin-1. Journal of Biological Chemistry 274:21217-21222 DOI 10.1074/jbc.274.30.21217.
20. Mamluk R, Gechtman Z, Kutcher ME, Gasiunas N, Gallagher J, Klagsbrun M. 2002. Neuropilin-1 binds vascular endothelial growth factor 165, placenta growth factor-2, and heparin via its b1b2 domain. Journal of Biological Chemistry 277:24818-24825 DOI 10.1074/jbc. M200730200.
21. Matsushita A, Gotze T, Korc M. 2007. Hepatocyte growth factor mediated cell invasion in pancreatic cancer cells is dependent on neuropilin-1. Cancer Research 67:10309-10316 DOI 10.1158/0008-5472.CAN-07-3256.
22. Migdal M, Huppertz B, Tessler S, Comforti A, Shibuya M, Reich R, Baumann H, Neufeld G. 1998. Neuropilin-1 is a placenta growth factor-2 receptor. Journal of Biological Chemistry 273:22272-22278 DOI 10.1074/jbc.273.35.22272.
23. Molina E, Hermida J, Lopez-Sagaseta J, Puy C, Montes R. 2008. The functional properties of a truncated form of endothelial cell protein C receptor generated by alternative splicing. Haematologica 93:878-884 DOI 10.3324/haematol.12376.
24. Murphy KJ, Merry CL, Lyon M, Thompson JE, Roberts IS, Gallagher JT. 2004. A new model for the domain structure of heparan sulfate based on the novel specificity of K5 lyase. Journal of Biological Chemistry 279:27239-27245 DOI 10.1074/jbc. M401774200.
25. Nakagawa Y, Capetillo S, Jirgensons B. 1972. Effect of chemical modification of lysine residues on the conformation of human immunoglobulin G. Journal of Biological Chemistry 247:5703-5708.
26. Nakamura F, Tanaka M, Takahashi T, Kalb RG, Strittmatter SM. 1998. Neuropilin-1 extracellular domains mediate semaphorin D/III-induced growth cone collapse. Neuron 21:1093-1100 DOI 10.1016/S0896-6273(00)80626-1.
27. Narazaki M, Segarra M, Tosato G. 2008. Sulfated polysaccharides identified as inducers of neuropilin-1 internalization and functional inhibition of VEGF165 and semaphorin3A. Blood 111:4126-4136 DOI 10.1182/blood-2007-09-112474.
28. Ori A, Free P, Courty J, Wilkinson MC, Fernig DG. 2009. Identification of heparin binding sites in proteins by selective labelling. Molecular Cellular Proteomics 10:2256-2265 DOI 10.1074/mcp. M900031-MCP200.
29. Ori A, Wilkinson MC, Fernig DG. 2008. The heparanome and regulation of cell function: structures, functions and challenges. Frontiers in Bioscience 13:4309-4338 DOI 10.2741/3007.
30. Popplewell JF, Swann MJ, Ahmed Y, Turnbull JE, Fernig DG. 2009. Fabrication of carbohydrate surfaces by using nonderivatised oligosaccharides, and their application to measuring the assembly of sugar-protein complexes. Chembiochem 10:1218-1226 DOI 10.1002/cbic.200800696.
31. Powell AK, Ahmed YA, Yates EA, Turnbull JE. 2010. Generating heparan sulfate saccharide libraries for glycomics applications. Nature Protocols 5:821-833 DOI 10.1038/nprot.2010.17.
32. Rahmoune H, Gallagher JT, Rudland PS, Fernig DG. 1998. Interaction of heparan sulphate from mammary cells with extracellular regulatory proteins. Acidic and fibroblast growth factor: regulation of the activity of bFGF by high and low affinity binding sites in heparan sulphate. Journal of Biological Chemistry 273:7303-7310 DOI 10.1074/jbc.273.13.7303.
33. Rudd TR, Guimond SE, Skidmore MA, Duchesne L, Guerrini M, Torri G, Cosentino C, Brown A, Clarke DT, Turnbull JE, Fernig DG, Yates EA. 2007. Influence of substitution pattern and cation binding on conformation and activity in heparin derivatives. Glycobiology 17:983-993 DOI 10.1093/glycob/cwm062.
34. Sadir R, Forest E, Lortat-Jacob H. 1998. The heparan sulfate binding sequence of interferongamma increased the on rate of the interferon-gamma-interferon-gamma receptor complex formation. Journal of Biological Chemistry 273:10919-10925 DOI 10.1074/jbc.273.18.10919.
35. Sasaki T, Larsson H, Kreuger J, Salmivirta M, Claesson-Welsh L, Lindahl U, Hohenester E, Timpl R. 1999. Structural basis and potential role of heparin/heparan sulfate binding to the angiogenesis inhibitor endostatin. EMBO Journal 18:6240-6248 DOI 10.1093/emboj/18.22.6240.
36. Shaw JP, Johnson Z, Borlat F, Zwahlen C, Kungl A, Roulin K, Harrenga A, Wells TN, Proudfoot AE. 2004. The X-ray structure of RANTES: heparin-derived disaccharides allows the rational design of chemokine inhibitors. Structure 12:2081-2093 DOI 10.1016/j.str.2004.08.014.
37. Soker S, Fidder H, Neufeld G, Klagsbrun M. 1996. Characterization of novel vascular endothelial growth factor (VEGF) receptors on tumor cells that bind VEGF165 via its exon 7-encoded domain. Journal of Biological Chemistry 271:5761-5767 DOI 10.1074/jbc.271.10.5761.
38. Soker S, Gollamudi-Payne S, Fidder H, Charmahelli H, Klagsbrun M. 1997. Inhibition of vascular endothelial growth factor (VEGF)-induced endothelial cell proliferation by a peptide corresponding to the exon 7-encoded domain of VEGF165. Journal of Biological Chemistry 272:31582-31588 DOI 10.1074/jbc.272.50.3158
39. Soker S, Takashima S, Miao HQ, Neufeld G, Klagsbrun M. 1998. Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell 92:735-745 DOI 10.1016/S0092-8674(00)81402-6.
40. Staton CA, Kumar I, Reed MW, Brown NJ. 2007. Neuropilins in physiological and pathological angiogenesis. Journal of Pathology 212:237-248 DOI 10.1002/path.2182.
41. Swendeman S, Mendelson K, Weskamp G, Horiuchi K, Deutsch U, Scherle P, Hooper A, Rafii S, Blobel CP. 2008. VEGF-A stimulates ADAM17-dependent shedding of VEGFR2 and crosstalk between VEGFR2 and ERK signaling. Circulation Research 103:916-918 DOI 10.1161/CIRCRESAHA.108.184416.
42. Thompson JD, Higgins DG, Gibson TJ. 1994. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Research 22:4673-4680 DOI 10.1093/nar/22.22.4673.
43. Torri G, Casu B, Gatti G, Petitou M, Choay J, Jacquinet JC, Sinay P. 1985. Mono-and bidimensional 500 MHz 1H-NMR spectra of a synthetic pentasaccharide corresponding to the binding sequence of heparin to antithrombin-III: evidence for conformational peculiarity of the sulfated iduronate residue. Biochemical and Biophysical Research Communications 128:134-140 DOI 10.1016/0006-291X(85)91655-9.
44. Uniewicz KA, Cross MJ, Fernig DG. 2010. Exogenous recombinant dimeric neuropilin-1 is sufficient to drive angiogenesis. Journal of Biological Chemistry 286:12-23 DOI 10.1074/jbc. M110.190801.
45. Uniewicz KA, Fernig DG. 2008. Neuropilins: a versatile partner of extracellular molecules that regulate development and disease. Frontiers in Bioscience 13:4339-4360 DOI 10.2741/3008.
46. Uniewicz KA, Ori A, Xu R, Ahmed Y, Wilkinson MC, Fernig DG, Yates EA. 2010. Differential scanning fluorimetry measurement of protein stability changes upon binding to glycosaminoglycans: a screening test for binding specificity. Analytical Chemistry 82:3796-3802 DOI 10.1021/ac100188x.
47. Valdembri D, Caswell PT, Anderson KI, Schwarz JP, Konig I, Astanina E, Caccavari F, Norman JC, Humphries MJ, Bussolino F, Serini G. 2009. Neuropilin-1/GIPC1 signaling regulates alpha5beta1 integrin traffic and function in endothelial cells. PLoS Biology 7:e25 DOI 10.1371/journal.pbio.1000025.
48. Vander Kooi CW, Jusino MA, Perman B, Neau DB, Bellamy HD, Leahy DJ. 2007. Structural basis for ligand and heparin binding to neuropilin B domains. Proceedings of the National Academy of Sciences of the United States of America 104:6152-6157 DOI 10.1073/pnas.0700043104.
49. Vanpouille C, Deligny A, Delehedde M, Denys A, Melchior A, Lienard X, Lyon M, Mazurier J, Fernig DG, Allain F. 2007. The heparin/heparan sulfate sequence that interacts with cyclophilin B contains a 3-O-sulfated N-unsubstituted glucosamine residue. Journal of Biological Chemistry 282:24416-24429 DOI 10.1074/jbc. M701835200.
50. West DC, Duchesne CG, Patey L, Terry SJ, Turnbull CJ, Delehedde JE, Heegaard M, Allain CW, Vanpouille F, Ron C, Fernig D. 2005. Interactions of multiple heparin binding growth factors with neuropilin-1 and potentiation of the activity of fibroblast growth factor-2. Journal of Biological Chemistry 280:13457-13464 DOI 10.1074/jbc. M410924200.
51. Whitaker GB, Limberg BJ, Rosenbaum JS. 2001. Vascular endothelial growth factor receptor-2 and neuropilin-1 form a receptor complex that is responsible for the differential signaling potency of VEGF(165) and VEGF(121). Journal of Biological Chemistry 276:25520-25531 DOI 10.1074/jbc. M102315200.
52. Xu D, Suenaga N, Edelmann MJ, Fridman R, Muschel RJ, Kessler BM. 2008. Novel MMP-9 substrates in cancer cells revealed by a label-free quantitative proteomics approach. Molecular Cellular Proteomics 7:2215-2228 DOI 10.1074/mcp. M800095-MCP200.
53. Xu R, Ori A, Rudd TR, Uniewicz KA, Ahmed YA, Guimond SE, Skidmore MA, Siligardi G, Yates EA, Fernig DG. 2012. Diversification of the structural determinants of fibroblast growth factor-heparin interactions: implications for binding specificity. Journal of Biological Chemistry 287:40061-40073 DOI 10.1074/jbc. M112.398826.
54. Yates EA, Santini F, Guerrini M, Naggi A, Torri G, Casu B. 1996. 1H and 13C NMR spectral assignments of the major sequences of twelve systematically modified heparin derivatives. Carbohydrate Research 294:15-27 DOI 10.1016/S0008-6215(96)90611-4.